期刊文献+

丙酮酸脱氢酶复合体的研究进展及应用 被引量:12

Development and application of pyrurate dehydrogenase complex
下载PDF
导出
摘要 综述了丙酮酸脱氢酶复合体(PDHc)的组成、结构功能、调控机制、缺陷疾病及在医学和农业中的应用.丙酸酸脱氢酶系是定位在线粒体中的多酶复合体,它是由丙酮酸脱氢酶(E1)、二氢硫辛酸乙酰转移酶(E2)、二氢硫辛酸脱氢酶(E3)和一些辅助因子组成.高等生物中PDHc活性的调节主要是通过对其E1的磷酸化和去磷酸化来实现的,而细菌的PDHc的活性主要是通过别构效应来调节,PDHc缺陷导致代谢障碍,组织受损. The article reviewes the PDHc briefly in structure, functional, activity regulation, deficiency, application in medicine and agriculture. PDHc is a mitochondrial multienzyme complex including pyruvate dehydrogenase(E1), dihydrolipoamide acetyltransferase(E2), dihydrolipoamide dehydrogenase(E3), and some cofactor and protein X. Through the phosphorylation and dephosphorylation of the E1 (pyruvate dehydrogenase, PDH) of the PDHc, the activity of mammalian pyruvate dehydrogenase complex has been regulated. While the allosteric control is the main regulatory mechanism in the bacterial. If the PDHc is deficient, it may induce holdback of metabolism and the organism may be suffered.
出处 《西北师范大学学报(自然科学版)》 CAS 2007年第6期79-83,共5页 Journal of Northwest Normal University(Natural Science)
关键词 丙酮酸脱氢酶复合体(PDHc) 调控机制 缺陷疾病 pyruvate dehydrogenase complex(PDHc) regulation mechanism deficiency
  • 相关文献

参考文献24

  • 1CISZAK E K L G,HONG Y S.Crystallization and initial X-ray diffraction analysis of human pyruvate dehydrogenase[J].Biological Crystallography,2001,57:465-468.
  • 2AGIUS L.Channeling in Intermediary Metabolism[M].London:Portland press,1996,115-132.
  • 3STOOPSK J,T S B,SCHROETER J P.Threedimensional structure of truncate dihydrolipoamide acetyltransferase[J].The Journal of Biological Chemistry,1992,267(34):24769-24775.
  • 4RANDLE P J,SUGDEN P H,KIRBEY A L.Regulation of mam-malian pyruvate dehydrogenase complex[J].Biochem SocSymp,1978,43:47-67.
  • 5ROCHE T E,RAHMATULLAH M,LI L.The lipoyl-containing components of the mammalian pyruvate dehydrogenase complex[J].Ann NY Acad Sci,1989,573:168-174.
  • 6DOUGLAS S F,PERRY A F.Inactivation of the pyreovate dehydrogenase complex of escherichhia coli by Fluoropyruvate[J].Biochemistry,1989,28:9594-9602.
  • 7REED L J,OLIVER R M.Brookhaven symp[J].Biol,1968,21:397-411.
  • 8ZEVIANI M,TARONI F.Mitochondrial diseases[J].Baillieres ClinNeurol,1994,3(2):315-334.
  • 9孙芳,戚豫,王丽,杨艳玲.Leigh综合征的临床和分子遗传学研究进展[J].中国当代儿科杂志,2005,7(2):186-189. 被引量:11
  • 10ROBINSON B H,MACKAY N,CHUN K,et al.Disorders of pyruvate carboxylase and the pyruvate dehydrogenase complex[J].Inherit Metab Dis,1996,19(4):452-462.

二级参考文献25

  • 1贺红武,汪军,刘钊杰,万树青,陆爱红.具有生物活性的有机磷化合物的研究V,α-[(取代)芳氧基乙酰氧基]烷基膦酸酯的合成和性质[J].应用化学,1994,11(4):21-24. 被引量:22
  • 2贺红武,华中师范大学学报,1994年,8卷,1期,71页
  • 3贺红武,有机化学,1993年,13卷,155页
  • 4闻之梅 陈君石.现代营养学[M].北京:人民卫生出版社,1998.310-313.
  • 5Valanne L, Ketonen L, Majander A, Suomalainen A, Pihko H.Neurological finding in children with mitochondrial disorders [J].Am J Neuroradiol, 1998, 19(2): 369-377.
  • 6Smeitink JA, van den Heuvel L, DiMauro S. The genetics and pathology of oxidative phosphorylation[J]. Nat Rev Genet, 2001, 2(5): 342-352.
  • 7Smeitink JA, Loeffen JL, Triepels RH, Smeets R J, Trijbels JM,van den Heuvel LP. Nuclear genes of human complex I of the mitochondrial electron transport chain: state of the art [ J ]. Hum Mol Genet, 1998, 7(10): 1573-1579.
  • 8Dimauro S, Schon EA. Mitochondrial DNA mutation in human disease[J]. Am J Med Gene, 2001, 106 (1): 18-26.
  • 9Absalon MJ, Harding CO, Fain DR, Li L, Mack KJ. Leigh syndrome in an infant resulting from mitochondrial DNA depletion[J]. Pediatr Neurol, 2001, 24(1): 60-63.
  • 10Mootha VK, Lepage P, Miller K, Bunkenborg J, Reich M, Hjerrild M, et al. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics [ J ]. Proc Natl Acad Sci U S A, 2003, 100(2): 605-610.

共引文献36

同被引文献128

引证文献12

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部